IRIS

Drug resistance in highly aggressive acute leukemias is controlled by de novo, expressed NG2 proteoglycan acting via modulation of selected transporters / Cattaruzza, S., Tommasetti, G., Bertani, N., Pala, S., Montanini, L., Stallcup, W.b., Colombatti, A., Perris, R.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 1879-0852. - 4:(2006), pp. 55-55. [10.1016/S1359-6349(06)70181-1]

Drug resistance in highly aggressive acute leukemias is controlled by de novo, expressed NG2 proteoglycan acting via modulation of selected transporters

BERTANI, Nicoletta;PERRIS, Roberto
2006-01-01
2006
Drug resistance in highly aggressive acute leukemias is controlled by de novo, expressed NG2 proteoglycan acting via modulation of selected transporters / Cattaruzza, S., Tommasetti, G., Bertani, N., Pala, S., Montanini, L., Stallcup, W.b., Colombatti, A., Perris, R.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 1879-0852. - 4:(2006), pp. 55-55. [10.1016/S1359-6349(06)70181-1]
4.1a Atto convegno Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2813609
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact